184 related articles for article (PubMed ID: 33854587)
1. A Novel Immunotype-based Risk Stratification Model Predicts Postoperative Prognosis and Adjuvant TACE Benefit in Chinese Patients with Hepatocellular Carcinoma.
Li TE; Zhang Z; Wang Y; Xu D; Dong J; Zhu Y; Wang Z
J Cancer; 2021; 12(10):2866-2876. PubMed ID: 33854587
[No Abstract] [Full Text] [Related]
2. A New Prognostic Algorithm Predicting HCC Recurrence in Patients With Barcelona Clinic Liver Cancer Stage B Who Received PA-TACE.
Hu S; Gan W; Qiao L; Ye C; Wu D; Liao B; Yang X; Jiang X
Front Oncol; 2021; 11():742630. PubMed ID: 34745962
[TBL] [Abstract][Full Text] [Related]
3. Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer.
Fu H; Zhu Y; Wang Y; Liu Z; Zhang J; Xie H; Fu Q; Dai B; Ye D; Xu J
Clin Cancer Res; 2018 Jul; 24(13):3069-3078. PubMed ID: 29514839
[No Abstract] [Full Text] [Related]
4. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant trans-arterial chemoembolization after hepatectomy significantly improves the prognosis of low-risk patients with R0-stage hepatocellular carcinoma.
Xie H; Tian S; Cui L; Yan J; Bai Y; Li X; Wang M; Zhang F; Duan F
Cancer Manag Res; 2019; 11():4065-4073. PubMed ID: 31118814
[No Abstract] [Full Text] [Related]
6. Development and Validation of a Prediction Model for Hepatitis B Virus-Related Hepatocellular Carcinoma Patients Receiving Postoperative Adjuvant Transarterial Chemoembolization.
Tu X; Zhang J; Li M; Lu F; Wang T; Gong W; Xiang B
J Hepatocell Carcinoma; 2023; 10():1881-1895. PubMed ID: 37901717
[TBL] [Abstract][Full Text] [Related]
7. Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.
He CB; Lao XM; Lin XJ
Chin J Cancer; 2017 Jul; 36(1):59. PubMed ID: 28728568
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
9. Glutamine synthetase predicts adjuvant TACE response in hepatocellular carcinoma.
Zhang B; Liu K; Zhang J; Dong L; Jin Z; Zhang X; Xue F; He J
Int J Clin Exp Med; 2015; 8(11):20722-31. PubMed ID: 26884995
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Nomogram for Hepatitis B Virus-related Hepatocellular Carcinoma With Adjuvant Transarterial Chemoembolization After Radical Resection.
Huang J; Liu FC; Li L; Yuan SX; Yang Y; Jiang BG; Liu H; Pan ZY
Am J Clin Oncol; 2020 Jan; 43(1):20-27. PubMed ID: 31633514
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant Transarterial Chemoembolization Following Liver Resection for Intrahepatic Cholangiocarcinoma Based on Survival Risk Stratification.
Li J; Wang Q; Lei Z; Wu D; Si A; Wang K; Wan X; Wang Y; Yan Z; Xia Y; Lau WY; Wu M; Shen F
Oncologist; 2015 Jun; 20(6):640-7. PubMed ID: 25956404
[TBL] [Abstract][Full Text] [Related]
12. Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection.
Jing CY; Fu YP; Zheng SS; Yi Y; Shen HJ; Huang JL; Xu X; Lin JJ; Zhou J; Fan J; Ren ZG; Qiu SJ; Zhang BH
Medicine (Baltimore); 2017 Mar; 96(11):e6140. PubMed ID: 28296727
[TBL] [Abstract][Full Text] [Related]
13. A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma.
Lee IC; Hung YW; Liu CA; Lee RC; Su CW; Huo TI; Li CP; Chao Y; Lin HC; Hou MC; Huang YH
Liver Int; 2019 Sep; 39(9):1704-1712. PubMed ID: 31319016
[TBL] [Abstract][Full Text] [Related]
14. Validation of the six-and-twelve criteria among patients with hepatocellular carcinoma and performance score 1 receiving transarterial chemoembolization.
Wang ZX; Li J; Wang EX; Xia DD; Bai W; Wang QH; Yuan J; Li XM; Niu J; Yin ZX; Xia JL; Fan DM; Han GH
World J Gastroenterol; 2020 Apr; 26(15):1805-1819. PubMed ID: 32351295
[TBL] [Abstract][Full Text] [Related]
15. Identification of
Shi M; Wang Y; Tang W; Cui X; Wu H; Tang Y; Wang P; Wu W; Zhang H
Ann Transl Med; 2020 Mar; 8(6):321. PubMed ID: 32355765
[TBL] [Abstract][Full Text] [Related]
16. Serum alanine aminotransferase to hemoglobin ratio and radiological features predict the prognosis of postoperative adjuvant TACE in patients with hepatocellular carcinoma.
Xia Z; Zhao Y; Zhao H; Zhang J; Liu C; Lu W; Wang L; Chen K; Yang J; Zhu J; Zhao W; Shen A
Front Oncol; 2022; 12():989316. PubMed ID: 36185225
[TBL] [Abstract][Full Text] [Related]
17. The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis.
Yang J; Liang H; Hu K; Xiong Z; Cao M; Zhong Z; Yao Z; Deng M
Cancer Cell Int; 2021 Feb; 21(1):92. PubMed ID: 33549093
[TBL] [Abstract][Full Text] [Related]
18. Tumor Size Affects Efficacy of Adjuvant Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Microvascular Invasion.
Liu S; Li H; Guo L; Zhang B; Zhou B; Zhang W; Zhou J; Fan J; Ye Q
Oncologist; 2019 Apr; 24(4):513-520. PubMed ID: 30552155
[TBL] [Abstract][Full Text] [Related]
19. Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: a retrospective control study.
Ren ZG; Lin ZY; Xia JL; Ye SL; Ma ZC; Ye QH; Qin LX; Wu ZQ; Fan J; Tang ZY
World J Gastroenterol; 2004 Oct; 10(19):2791-4. PubMed ID: 15334671
[TBL] [Abstract][Full Text] [Related]
20. CT-Based Radiomics for the Recurrence Prediction of Hepatocellular Carcinoma After Surgical Resection.
Wang F; Chen Q; Zhang Y; Chen Y; Zhu Y; Zhou W; Liang X; Yang Y; Hu H
J Hepatocell Carcinoma; 2022; 9():453-465. PubMed ID: 35646748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]